Bridging the gap between R&D Project and clinical Development
From Regenerative Medicine to Immuno-Oncology,
From Autologous strategy to Allogeneic approach,
From Manufacturing Process, Analytics Bioassays, Quality Control Testing to Stability studies,
your project requirements are our priorities at any time
Beyond classical Contract Development and Manufacturing Organization (CDMO) offer, we assist our customers not only on GMP manufacturing but from Cell sourcing to Fill&Finish with an expert assistance on regulatory aspects.
Analytics-driven CDMO specialized in Cell Therapy, Cell-Easy provides customized Process Development, GMP Manufacturing and unique Analytical Services in Regenerative Medicine and Immuno-Oncology fields.
Always keeping in mind delays and flexibility to perfectly fit with clients’ expectations.
Discover morePress
28.02.2022
The OPTI-STEM consortium led by Cell-Easy to democratize access to cell therapy in France and Europe
Toulouse, La Madeleine, Nancy, France – 28 February, 2022 The […]
Press
07.02.2022
Virginie Duel joins Cell-Easy as Head of Quality Control.
The Cell-Easy management team is very pleased to […]